Alzamend Neuro
NASDAQ: ALZN
Healthcare
Biotechnology
Rank
#43458
Market Cap
3.78 M
Volume
159,614
Price
5.15
Change (%)
13.01%
Country or region
United States
United States
Alzamend Neuro Stock Split History Overview
This company has undergone a total of three stock splits throughout its history. Three reverse splits occurred, consolidating shares and stabilizing stock prices. The most recent split occurred on May 12, 2025 with a ratio of 1-for-9. These adjustments reflect the company's strategic efforts to align stock performance with market conditions.
Alzamend Neuro (NASDAQ: ALZN) Stock Split History
| Date | Split Ratio | Multiple | Cumulative multiple | Type |
|---|---|---|---|---|
| May 12, 2025 | 1:9 | x0.11111111 | x0.0007407408 | Reverse |
| July 16, 2024 | 1:10 | x0.1 | x0.0066666673 | Reverse |
| October 31, 2023 | 1:15 | x0.06666667 | x0.06666667 | Reverse |
Frequently Asked Questions
If Alzamend Neuro (stock symbol: NASDAQ: ALZN) had never undergone any stock splits, its price per share today would be approximately 0.00 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1-for-9) that occurred on May 12, 2025.
Alzamend Neuro (stock symbol: NASDAQ: ALZN) has undergone a total of three stock splits. The most recent split occurred on May 12, 2025. One share bought prior to the first split on October 31, 2023 would now equal 0.00 shares.
Alzamend Neuro (stock symbol: NASDAQ: ALZN) has undergone three stock splits in its history. The most recent split, a 1-for-15 split, occurred on May 12, 2025. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.
